Compare
FTI Consulting, Inc vs Astrana Health, Inc. vs Genpact Ltd vs Huron Consulting Group Inc.
| Latest fiscal year | FTI Consulting, Inc FCN | Astrana Health, Inc. ASTH | Genpact Ltd G | Huron Consulting Group Inc. HURN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $3.79B | $3.18B | $5.08B | $1.70B |
| Revenue growth (YoY) | +2.4% | +56.4% | +6.6% | +11.7% |
| Gross margin | 32.1% | n/a | 36.0% | n/a |
| Operating margin | 10.3% | 2.5% | 14.8% | 10.5% |
| Net margin | 7.1% | 0.7% | 10.9% | 6.2% |
| Net income | $270.87M | $22.49M | $552.49M | $105.04M |
| EPS (Diluted) | $8.24 | $0.46 | $3.13 | $5.84 |
| Operating cash flow | $152.13M | $114.60M | $812.86M | $193.39M |
| Free cash flow | $93.60M | $104.49M | $734.65M | $182.96M |
| Cash & equivalents | $265.09M | $429.47M | $853.84M | $24.51M |
| Total assets | $3.49B | $2.22B | $5.84B | $1.53B |
| Total liabilities | $1.76B | $1.66B | $3.29B | n/a |
| Shareholders' equity | $1.73B | $779.29M | $2.55B | $528.63M |
| Return on year-end equity | 15.6% | 2.9% | 21.7% | 19.9% |
| Shares outstanding | 30.86M | 48.89M | 170.34M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | FTI Consulting, Inc | Astrana Health, Inc. | Genpact Ltd | Huron Consulting Group Inc. |
|---|---|---|---|---|
| Latest | $3.79B Ended 2025-12-31 | $3.18B Ended 2025-12-31 | $5.08B Ended 2025-12-31 | $1.70B Ended 2025-12-31 |
| 1 year earlier | $3.70B Ended 2024-12-31 | $2.03B Ended 2024-12-31 | $4.77B Ended 2024-12-31 | $1.52B Ended 2024-12-31 |
| 2 years earlier | $3.49B Ended 2023-12-31 | $1.39B Ended 2023-12-31 | $4.48B Ended 2023-12-31 | $1.40B Ended 2023-12-31 |
| 3 years earlier | $3.03B Ended 2022-12-31 | $1.14B Ended 2022-12-31 | $4.37B Ended 2022-12-31 | $1.16B Ended 2022-12-31 |
| 4 years earlier | $2.78B Ended 2021-12-31 | $773.91M Ended 2021-12-31 | $4.02B Ended 2021-12-31 | $926.96M Ended 2021-12-31 |